Das Spital Emmental beschafft Kapital von CHF 120 Mio.
Das Spital Emmental beschafft Kapital von CHF 120 Mio.
Das Spital Emmental ist ein bedeutendes Regionalspital in der Schweiz.
Das Team von Oaklins in der Schweiz beriet das Spital Emmental bei der Verhandlung der Finanzierungsbedingungen mit den Kapitalgebern.
Sprechen Sie mit dem Deal Team
Transaktionen
Sun European Partners has secured financing to support its acquisition of B&H Worldwide
Sun European Partners has raised debt facilities to support its acquisition of B&H Worldwide.
Mehr erfahrenInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Mehr erfahrenRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Mehr erfahren